Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation; Resistance

Press/Media

Period2 Oct 2018

Media coverage

1

Media coverage

  • TitleStudy of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation; Resistance
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date2/10/18
    PersonsDonna Mildvan,